Ryan J. Watts owns 1.51% of Denali Therapeutics
2,417,217 shares as of the August 12, 2026 filing, worth $42.6M at the latest close.
DNLI · $2.8B market cap · Founder-ledGet an email when Ryan J. Watts’s stake moves.
Free.
The stake
1.51%
worth $42.6M at the latest close
Stake rank
#795
by dollar value of the stake
Last sale
286 days ago
Jan 6, 2026
Last buy
None
no purchases since 2018
Ryan J. Watts owns 1.51% of Denali Therapeutics Inc.: 2,417,217 of 159,847,403 shares, worth about $42.6M at the 2026-10-16 close. The stake has moved from 2.97% in 2017 to 1.51% on 2026-08-12, across 46 sales and 0 purchases that moved it since 2016. The last trade that moved it was a discretionary sale of $580,767 on 2026-01-06.
How the stake is held
as of the Aug 12, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Aug 12, 2026 · Form 4 ↗
HELD DIRECTLY
296,833
12.3%
HELD INDIRECTLY · Indirect, per the filing’s footnote
2,120,384
87.7%
THE STAKE
2,417,217
1.51%